Axa’s Acacia Research ACTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23,700
Closed -$160K 1221
2021
Q2
$160K Buy
+23,700
New +$141K ﹤0.01% 1229
2019
Q4
Sell
-25,854
Closed -$69K 1163
2019
Q3
$69K Hold
25,854
﹤0.01% 1281
2019
Q2
$77K Hold
25,854
﹤0.01% 1263
2019
Q1
$84K Sell
25,854
-76,600
-75% -$238K ﹤0.01% 1298
2018
Q4
$305K Hold
102,454
﹤0.01% 1168
2018
Q3
$328K Sell
102,454
-56,964
-36% -$212K ﹤0.01% 1217
2018
Q2
$662K Hold
159,418
﹤0.01% 1092
2018
Q1
$558K Sell
159,418
-139,800
-47% -$512K ﹤0.01% 1139
2017
Q4
$1.21M Buy
299,218
+88,800
+42% +$376K ﹤0.01% 955
2017
Q3
$957K Buy
210,418
+99,500
+90% +$372K ﹤0.01% 964
2017
Q2
$455K Buy
110,918
+78,618
+243% +$366K ﹤0.01% 1073
2017
Q1
$186K Buy
+32,300
New +$189K ﹤0.01% 1227
2016
Q3
Sell
-27,600
Closed -$121K 1196
2016
Q2
$121K Buy
+27,600
New +$127K ﹤0.01% 1225

Other funds holding ACTG

Axa's ACTG Position: Q3 2021 in Review

Axa sold out of Acacia Research (ACTG) in Q3 2021, closing a stake of 23,700 shares — an estimated $160K sold.

Axa first reported a position in ACTG in Q2 2016 and held it in 13 quarters. The position peaked at $1.21M in Q4 2017. 102 funds tracked by Wall St. Rank hold ACTG as of Q3 2021.

  • Axa reported no remaining Acacia Research position as of Q3 2021 after selling out during the quarter.
  • Axa sold 23,700 Acacia Research shares in Q3 2021, an estimated $160K.
  • Axa first reported a position in Acacia Research in Q2 2016 and held it in 13 quarters.
  • Axa's Acacia Research position peaked at $1.21M in Q4 2017.
  • 102 funds tracked by Wall St. Rank held Acacia Research as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.